Liabilities and Equity of Intra-Cellular Therapies, Inc. from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Intra-Cellular Therapies, Inc. quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • Intra-Cellular Therapies, Inc. Liabilities and Equity for the quarter ending 31 Dec 2024 was $1,366,912,000, a 88% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

Intra-Cellular Therapies, Inc. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $1,366,912,000 +$638,617,000 +88% 31 Dec 2024 10-K 21 Feb 2025 2024 FY
Q3 2024 $1,324,445,000 +$606,781,000 +85% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $1,320,504,000 +$606,902,000 +85% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $747,036,000 +$24,878,000 +3.4% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $728,295,000 -$26,485,000 -3.5% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $717,664,000 -$64,335,000 -8.2% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $713,602,000 -$98,304,000 -12% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $722,158,000 -$146,422,000 -17% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $754,780,000 +$264,858,000 +54% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $781,999,000 +$225,023,266 +40% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $811,906,000 +$186,209,338 +30% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $868,580,000 +$194,091,432 +29% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $489,922,000 -$227,391,674 -32% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $556,975,734 -$214,318,075 -28% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $625,696,662 +$184,765,838 +42% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $674,488,568 +$193,245,851 +40% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $717,313,674 +$466,127,198 +186% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $771,293,809 +$490,770,779 +175% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $440,930,824 +$131,068,210 +42% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $481,242,717 +$138,269,900 +40% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $251,186,476 -$106,020,022 -30% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $280,523,030 -$105,064,168 -27% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $309,862,614 -$102,211,109 -25% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $342,972,817 -$102,666,255 -23% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $357,206,498 -$114,280,201 -24% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 $385,587,198 +$51,396,357 +15% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 $412,073,723 +$62,534,188 +18% 30 Jun 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 $445,639,072 +$73,346,766 +20% 31 Mar 2018 10-Q 03 May 2018 2018 Q1
Q4 2017 $471,486,699 +$82,583,204 +21% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q3 2017 $334,190,841 -$208,381,141 -38% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 $349,539,535 -$98,063,310 -22% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $372,292,306 -$91,369,534 -20% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 $388,903,495 -$95,200,033 -20% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 $542,571,982 +$29,449,673 +5.7% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 $447,602,845 +$234,198,815 +110% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 $463,661,840 +$226,534,035 +96% 31 Mar 2016 10-Q 28 Apr 2016 2016 Q1
Q4 2015 $484,103,528 +$352,991,759 +269% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 $513,122,309 +$375,513,071 +273% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 $213,404,030 +$72,061,220 +51% 30 Jun 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 $237,127,805 +$90,491,145 +62% 31 Mar 2015 10-Q 30 Apr 2015 2015 Q1
Q4 2014 $131,111,769 +$92,662,457 +241% 31 Dec 2014 10-K 25 Feb 2016 2015 FY
Q3 2014 $137,609,238 +$90,273,192 +191% 30 Sep 2014 10-Q 03 Nov 2014 2014 Q3
Q2 2014 $141,342,810 +$141,342,761 30 Jun 2014 10-Q 12 Aug 2014 2014 Q2
Q1 2014 $146,636,660 +$146,632,590 31 Mar 2014 10-Q 05 May 2014 2014 Q1
Q4 2013 $38,449,312 +$18,625,632 +94% 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q3 2013 $47,336,046 30 Sep 2013 10-Q 05 Nov 2013 2013 Q3
Q2 2013 $49* 30 Jun 2013 10-Q 15 Aug 2013 2013 Q1
Q1 2013 $4,070* 31 Mar 2013 10-Q 15 Aug 2013 2013 Q1
Q4 2012 $19,823,680 31 Dec 2012 10-K 25 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.